A business in context
NBIX research notebook
Read the disclosures. Follow the relationships. Keep the dates in view.
Filing timeline
Download filings CSVReported insider transactions
Download transactions CSVP · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift
| Transaction / filed | Reporting owner | Type | Security | Shares | Reported price |
|---|---|---|---|---|---|
| 2026-06-29 | Lippoldt Darin | M · Exercise / conversion | Common Stock | 1690.0 | 81.49 |
| 2026-06-29 | Lippoldt Darin | S · Sale | Common Stock | 1690.0 | 170.81 |
| 2026-06-29 | Lippoldt Darin | M · Exercise / conversion | Common Stock | 8110.0 | 81.49 |
| 2026-06-29 | Lippoldt Darin | S · Sale | Common Stock | 8110.0 | 170.03 |
| 2026-06-29 | Lippoldt Darin | M · Exercise / conversion | Non-Qualified Stock Option | 8110.0 | 0.0 |
| 2026-06-29 | Lippoldt Darin | M · Exercise / conversion | Non-Qualified Stock Option | 1690.0 | 0.0 |
| 2026-06-26 | Lippoldt Darin | M · Exercise / conversion | Common Stock | 200.0 | 81.49 |
| 2026-06-26 | Lippoldt Darin | S · Sale | Common Stock | 200.0 | 169.57 |
| 2026-06-26 | Lippoldt Darin | M · Exercise / conversion | Non-Qualified Stock Option | 200.0 | 0.0 |
| 2026-06-05 | Onyia Jude | G · Gift | Common Stock | 2441.0 | 0.0 |
| 2026-06-05 | SHERWIN STEPHEN A | M · Exercise / conversion | Common Stock | 15000.0 | 53.64 |
| 2026-06-05 | SHERWIN STEPHEN A | M · Exercise / conversion | Common Stock | 10000.0 | 79.79 |
| 2026-06-05 | SHERWIN STEPHEN A | S · Sale | Common Stock | 7883.0 | 163.81 |
| 2026-06-05 | SHERWIN STEPHEN A | S · Sale | Common Stock | 2549.0 | 164.44 |
| 2026-06-05 | SHERWIN STEPHEN A | S · Sale | Common Stock | 6896.0 | 165.79 |
| 2026-06-05 | SHERWIN STEPHEN A | S · Sale | Common Stock | 5829.0 | 166.56 |
| 2026-06-05 | SHERWIN STEPHEN A | S · Sale | Common Stock | 1843.0 | 167.31 |
| 2026-06-05 | SHERWIN STEPHEN A | M · Exercise / conversion | Non-Qualified Stock Option | 10000.0 | 0.0 |
| 2026-06-05 | SHERWIN STEPHEN A | M · Exercise / conversion | Non-Qualified Stock Option | 15000.0 | 0.0 |
| 2026-06-04 | Norwalk Leslie V | S · Sale | Common Stock | 1250.0 | 168.06 |
| 2026-06-02 | Keswani Sanjay Chandru | M · Exercise / conversion | Common Stock | 3212.0 | 0.0 |
| 2026-06-02 | Keswani Sanjay Chandru | F · Tax / exercise payment | Common Stock | 1733.0 | 154.84 |
| 2026-06-02 | Keswani Sanjay Chandru | M · Exercise / conversion | Restricted Stock Unit | 3212.0 | 0.0 |
| 2026-06-02 | Cooke Julie | M · Exercise / conversion | Common Stock | 24965.0 | 81.49 |
| 2026-06-02 | Cooke Julie | S · Sale | Common Stock | 3520.0 | 158.59 |
| 2026-06-02 | Cooke Julie | S · Sale | Common Stock | 9521.0 | 157.62 |
| 2026-06-02 | Cooke Julie | S · Sale | Common Stock | 4216.0 | 156.77 |
| 2026-06-02 | Cooke Julie | S · Sale | Common Stock | 5466.0 | 155.46 |
| 2026-06-02 | Cooke Julie | S · Sale | Common Stock | 14214.0 | 154.83 |
| 2026-06-02 | Cooke Julie | M · Exercise / conversion | Non-Qualified Stock Option | 24965.0 | 0.0 |
| 2026-06-01 | Onyia Jude | M · Exercise / conversion | Common Stock | 11000.0 | 84.74 |
| 2026-06-01 | Onyia Jude | S · Sale | Common Stock | 11000.0 | 160.25 |
| 2026-06-01 | Onyia Jude | M · Exercise / conversion | Non-Qualified Stock Option | 11000.0 | 0.0 |
| 2026-05-29 | Delaet Ingrid | M · Exercise / conversion | Common Stock | 2261.0 | 79.02 |
| 2026-05-29 | Delaet Ingrid | S · Sale | Common Stock | 2261.0 | 156.71 |
| 2026-05-29 | Delaet Ingrid | M · Exercise / conversion | Non-Qualified Stock Option | 2261.0 | 0.0 |
| 2026-05-27 | Onyia Jude | S · Sale | Common Stock | 11000.0 | 155.53 |
| 2026-05-27 | Onyia Jude | M · Exercise / conversion | Common Stock | 11000.0 | 84.74 |
| 2026-05-27 | Onyia Jude | M · Exercise / conversion | Non-Qualified Stock Option | 11000.0 | 0.0 |
| 2026-05-27 | Mercier Johanna | A · Grant / award | Restriced Stock Unit | 2567.0 | 0.0 |
| 2026-05-27 | Norwalk Leslie V | A · Grant / award | Restriced Stock Unit | 1284.0 | 0.0 |
| 2026-05-27 | Norwalk Leslie V | A · Grant / award | Non-Qualified Stock Option | 2624.0 | 0.0 |
| 2026-05-27 | Sharp Shalini | A · Grant / award | Restriced Stock Unit | 2567.0 | 0.0 |
| 2026-05-27 | RASTETTER WILLIAM H | A · Grant / award | Restriced Stock Unit | 2567.0 | 0.0 |
| 2026-05-27 | GORMAN KEVIN CHARLES | A · Grant / award | Non-Qualified Stock Option | 5248.0 | 0.0 |
| 2026-05-27 | POON CHRISTINE A | A · Grant / award | Restriced Stock Unit | 2567.0 | 0.0 |
| 2026-05-27 | POPS RICHARD F | A · Grant / award | Restriced Stock Unit | 2567.0 | 0.0 |
| 2026-05-27 | LYONS GARY A | A · Grant / award | Restriced Stock Unit | 1284.0 | 0.0 |
| 2026-05-27 | LYONS GARY A | A · Grant / award | Non-Qualified Stock Option | 2624.0 | 0.0 |
| 2026-05-27 | SHERWIN STEPHEN A | A · Grant / award | Restriced Stock Unit | 2567.0 | 0.0 |
Identity & relationships
SEC issuer · 0000914475NEUROCRINE BIOSCIENCES INC
- Legal Entity Identifier
- 549300FECER0XBN49756
- GLEIF legal name
- Neurocrine Biosciences, Inc.
- Entity / LEI registration status
- ACTIVE / LAPSED
- Reference data updated
- 2026-07-29T18:14:48Z
Search names and former names
View Wikidata identity and references ↗
- Neurocrine Biosciences · alias · wikidata
Revenue in constant purchasing power
| Year ended | Reported USD revenue | CPI-adjusted USD revenue |
|---|---|---|
| 2024-12-31 | $2.36B | $2.51B |
| 2023-12-31 | $1.89B | $2.07B |
| 2022-12-31 | $1.49B | $1.70B |
| 2021-12-31 | $1.13B | $1.40B |
| 2020-12-31 | $1.05B | $1.35B |
| 2019-12-31 | $788.10M | $1.03B |
| 2018-12-31 | $451.20M | $599.97M |
| 2017-12-31 | $161.63M | $220.17M |